Related Experiment Video
Updated: Aug 9, 2026
08:50
How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
Published on: December 14, 2014
Do medical devices have enhanced placebo effects?
T J Kaptchuk1, P Goldman, D A Stone
1Center for Alternative Medicine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. tkaptchu@caregroup.harvard.edu
Journal of Clinical Epidemiology
|August 16, 2000
Summary
The placebo effect in clinical trials might be stronger for medical devices. Further research is needed to understand device-enhanced placebo effects and their implications without compromising patient consent.
Area of Science:
- Medical research methodology
- Clinical trial design
- Psychosomatic medicine
Background:
- The placebo effect is a critical factor in clinical trial outcomes, not just a baseline.
- The potential for medical devices to amplify placebo effects requires investigation.
Purpose of the Study:
- To explore whether medical devices enhance placebo effects.
- To discuss the implications of enhanced placebo effects in clinical trials.
- To propose methods for studying device-enhanced placebo effects ethically.
Main Methods:
- Review of existing literature on placebo effects and medical devices.
- Conceptual analysis of the interaction between devices and psychosomatic responses.
- Ethical framework development for investigating enhanced placebo effects.
Main Results:
- Preliminary evidence suggests devices may indeed enhance placebo effects, though data is limited.
- The magnitude of the placebo effect can significantly influence trial results.
- Investigating this phenomenon is crucial for accurate clinical trial interpretation.
Conclusions:
- The potential for device-enhanced placebo effects warrants further rigorous scientific investigation.
- Ethical research methods can be developed to study this effect while respecting informed consent.
- Understanding amplified placebo responses is key to advancing clinical trial validity.
Related Concept Videos
01:54The Placebo Effect
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...